Sector portfolio · Corporate investor · United States
Sanofi Ventures' Biotech portfolio
Sanofi Ventures has backed 11 Biotech startups in rounds we track, $3.3B between them, shown by the stage each has reached. The best-funded is Kymera Therapeutics.
Funding by segment
- Series B$1.5B4
- Series C and later$1.5B3
- Series A$235M2
- Stage not reported$115M2
Where they are based
- United States8$1.9B
- Germany1$687M
- United Kingdom1$279M
- Australia1$438M
United States
Germany
United Kingdom
AustraliaFounded
1 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M0
- $10M to $50M1
- $50M to $250M5
- $250M to $1B5
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
10 of 11 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States8
- Germany1
- United Kingdom1
- Australia1
Startups by country, 4 countries in all.
Segment by segment
Series B
4 startups · $1.5B raised
- BBioNTechGermany$687M
Fulcrum TherapeuticsFulcrum Therapeutics is a biotechnology company that focuses on identifying and treating rare genetic diseases at their root cause.United States$310M
T-TherapeuticsT-Therapeutics is a next-generation T cell receptor (TCR) company spun off from the University of Cambridge.United Kingdom$279M
Matchpoint TherapeuticsMatchpoint Therapeutics is a biotechnology company based in Cambridge, Massachusetts, founded in 2021.United States$220M
Series C and later
3 startups · $1.5B raised
Kymera TherapeuticsKymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.United States$799M
AdvanCellAdvanCell is radiopharmaceutical firm that has developed the Targeted Alpha Therapy platform technology, a cutting-edge cancer treatment.Australia$438M
Science 37Science 37 is a clinical research company that facilitates universal participation in clinical trials for patients and providers.United States$236M
Series A
2 startups · $235M raised
IcosavaxIcosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs.United States$119M- IPInozyme PharmaUnited States$116M
Stage not reported
2 startups · $115M raised
AetionAetion provides real-world evidence (RWE) and outcomes-based analytics solutions to life science companies and payers.United States$74M
Veralox TherapeuticsVERALOX Therapeutics is a clinical-stage biotechnology company based in Frederick, Maryland.United States$41M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Sanofi Ventures as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like Sanofi Ventures?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.